Get started
Author

Machiko Fujioka

Treatment with mogamulizumab or lenalidomide for relapsed adult T‐cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience
2020 · Hikaru Sakamoto, Hidehiro Itonaga, et al. · Hematological Oncology · 29
Methotrexate-induced acute kidney injury in patients with hematological malignancies: three case reports with literature review
2018 · Mineaki Kitamura, Satoko Kitamura, et al. · Renal Replacement Therapy · 21
Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: a nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular Therapy
2024 · Hidehiro Itonaga, Yasushi Miyazaki, et al. · Bone Marrow Transplantation · 9
RAISING revealed a heterogenous pattern of HTLV-1 clonality after HLA-haploidentical peripheral blood stem cell transplantation for ATL
2023 · Hidehiro Itonaga, Takeharu Kato, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 8
Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome
2019 · Miki Hashimoto, Hidehiro Itonaga, et al. · Internal Medicine · 8
PDF
Outcome of donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation in relapsed myelodysplastic syndrome
2024 · Atsushi Marumo, Yasunobu Nagata, et al. · Cytotherapy · 6
PDF
Allogeneic transplantation for adult T‐cell leukemia/lymphoma in adolescent and young adults and young patients: A nationwide retrospective study by the ATL working group of the Japan society for transplantation and cellular therapy
2024 · Hidehiro Itonaga, Takuya Fukushima, et al. · Hematological Oncology · 6
PDF
Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study Group
2021 · Masahiko Chiwata, Hidehiro Itonaga, et al. · Internal Medicine · 6
PDF
Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma with HTLV-1-associated myelopathy
2021 · Hikaru Sakamoto, Hidehiro Itonaga, et al. · International Journal of Hematology · 6
Correction to: Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group
2020 · Sachie Kasai, Hidehiro Itonaga, et al. · International Journal of Hematology · 5
PDF
Prognostic Impact of Cytomegalovirus Reactivation After Transplantation From Cord Blood Compared to Other Donor Sources in Patients With Adult T‐Cell Leukemia/Lymphoma in the Pre‐Letermovir Era
2025 · Takuya Fukushima, Hidehiro Itonaga, et al. · Transplant Infectious Disease · 4
PDF
Superior Survival After Unrelated Allogeneic Stem Cell Transplantation With Low-Dose ATG Compared to Low-Dose TBI in Myeloablative Fludarabine/Busulfan-Based Regimen for MDS on Behalf of the Adult MDS Working Group of the JSTCT
2024 · Machiko Fujioka, Hidehiro Itonaga, et al. · Transplantation and Cellular Therapy · 4
[Progressive multifocal leukoencephalopathy during the treatment for mycosis fungoides].
2022 · Yasushi Sawayama, Takeharu Kato, et al. · PubMed · 4
Successful outcome of second allogeneic bone marrow transplantation for blastic plasmacytoid dendritic cell neoplasm with MYC locus rearrangement
2019 · Takeharu Kato, Hidehiro Itonaga, et al. · Leukemia Research Reports · 4
PDF
Single‐unit unrelated cord blood transplantation versus HLA‐matched sibling transplantation in adults with advanced myelodysplastic syndrome: A registry‐based study from the adult MDS working group of the Japanese society for transplantation and cellular therapy
2023 · Takaaki Konuma, Hidehiro Itonaga, et al. · Hematological Oncology · 3
PDF
Clinical features of non-infectious pulmonary complications after donor lymphocyte infusion in post-transplant patients: The Nagasaki Transplant Group Experience
2022 · Machiko Fujioka, Hidehiro Itonaga, et al. · Transplant Immunology · 3
PDF
Outcomes in Patients with Classic Hodgkin Lymphoma Treated with ABVD: A Single-center Retrospective Study
2020 · Junya Makiyama, Yoshitaka Imaizumi, et al. · Internal Medicine · 3
PDF
Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group
2020 · Sachie Kasai, Hidehiro Itonaga, et al. · International Journal of Hematology · 3
Efficacy of Azacitidine Plus Venetoclax in Acute Myeloid Leukemia Transformed from Myelodysplastic Syndrome after Failure of Azacitidine Monotherapy
2025 · Takafumi Furumoto, Koji Ando, et al. · Internal Medicine · 2
PDF
Bone marrow versus peripheral blood stem cells as the graft source for allogeneic transplantation from HLA-matched relative donors in adult T-cell leukemia/lymphoma: A nationwide retrospective study by the ATL working group of the Japanese Society for Transplantation and Cellular Therapy
2025 · Hidehiro Itonaga, Takuya Fukushima, et al. · Bone Marrow Transplantation · 2
The response-guided ATG treatment provides a survival benefit and KPS recovery for patients with steroid refractory acute GVHD: The Nagasaki Transplant Group Experience
2021 · Machiko Fujioka, Hidehiro Itonaga, et al. · Transplant Immunology · 2
PDF
[Durable remission attained with plasmapheresis and intravenous immunoglobulin therapy in a patient with acute exacerbation of GVHD-related myasthenia gravis].
2018 · Jun Nakashima, Hidehiro Itonaga, et al. · PubMed · 2
High-dose Chemotherapy with Stem Cell Rescue Provided Durable Remission for Classical Hodgkin Lymphoma-type Post-transplant Lymphoproliferative Disorder after Unrelated Cord Blood Transplantation: A Case Report and Review of the Literature
2017 · Hidehiro Itonaga, Takeharu Kato, et al. · Internal Medicine · 2
PDF
Prognostic factors of second allogeneic hematopoietic stem cell transplantation for relapsed or refractory myelodysplastic syndromes: nationwide registry analysis
2026 · Kamma Shiraishi, Yoshimitsu Shimomura, et al. · Bone Marrow Transplantation · 1
Clinical Relevance of Transplant Conditioning Intensity Score-Based Refinement of Conditioning Intensity in Cord Blood Transplantation for Myelodysplastic Syndrome
2026 · Machiko Fujioka, Hidehiro Itonaga, et al. · Transplantation and Cellular Therapy · 1
Works count: 45
Citation count: 150
H-index: 6
I10-index: 2
Year
Topic
Type